SCHEMBL30498302

SCHEMBL30498302

FC(F)(F)Cn1cc(I)c2c(Cl)ncnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 6/20 0.41
▸ SLC29A1 Q99808 1/20 0.41
▸ DYRK3 O43781 1/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ PRKD3 O94806 1/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ PHKG2 P15735 1/20 0.37
▸ PRKACA P17612 1/20 0.37
▸ RPS6KB1 P23443 1/20 0.37
▸ MARK3 P27448 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ CSNK1D P48730 1/20 0.37
▸ CLK2 P49760 1/20 0.37
▸ IRAK1 P51617 1/20 0.37
▸ CSNK1G2 P78368 1/20 0.37
▸ MAP4K2 Q12851 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ CAMK2G Q13555 1/20 0.37
▸ CAMK2D Q13557 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236447 1.00 ADK (0.41) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL16236464 0.85 ADK (0.40) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL18045177 0.85 ADK (0.44) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL16236999 0.83 ADK (0.46) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL29503417 0.83 ADK (0.46) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL16236954 0.82 DYRK3 (0.56) ADKDYRK3ROCK2PRKD3MAP4K4
SCHEMBL31568623 0.82 DYRK3 (0.56) ADKDYRK3ROCK2PRKD3MAP4K4
SCHEMBL23630551 0.80 ADK (0.43) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL16236535 0.80 ADK (0.44) ADKSLC29A1DYRK3ROCK2PRKD3
SCHEMBL16236456 0.78 ADK (0.43) ADKSLC29A1DYRK3ROCK2PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448514-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF Lynk Pharmaceuticals Co. Ltd. (CN) 2024-10-23 — — EP disclosed
WO-2023109954-A1 TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF LYNK PHARMACEUTICALS CO. LTD. (CN) 2023-06-22 — — WO disclosed
Send feedback